Leukapheresis Industry Size

Leukapheresis Market worth $100 million by 2028

The report "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) - Global Forecast to 2028", is anticipated to reach USD 100 million by 2028 from USD 70 million in 2023, at a CAGR of 8.3%. The global leukopaks market is anticipated to reach USD 1020 million by 2028 from USD 200 million in 2023, at a CAGR of 38.1%. The leukopaks market is driven by the increasing demand for leukopaks in research applications, such as the development of new cancer treatments. The demand for leukopaks is growing due to the increasing number of research studies being conducted on cancer. The development of new cancer treatments is also driving the demand for leukopaks. Other factors that are contributing to the growth of the leukopaks market include the increasing incidence and prevalence of cancer, the growing popularity of personalized medicine, advances in medical technology, and growing awareness about leukopaks and their benefits in developing nations.

Browse 259 market data Tables and 79 Figures spread through 330 Pages and in-depth TOC on "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/leukapheresis-market-20283148.html

In this report, the overall leukapheresis market is divided into the leukapheresis products market and the Leukopaks Market. The leukapheresis products Market is classified into segments including type, application, end user, and region, and the leukopaks Market is classified into segments such as type, indication, end user, and region.

The disposables segment accounted for the larger share of the leukapheresis products market.

By type, the leukapheresis products market can be segmented into devices and disposables. The disposables segment occupied a larger share of the leukapheresis products market in 2022. The disposables used in leukapheresis procedures are products used to access blood vessels and store blood components, replacement fluids, and anticoagulants to prevent blood from clotting in the process. Disposables are used for both automated blood collection and therapeutic leukapheresis. They include apheresis catheters, needle sets, centrifuge bowls, tubing sets/pipeline systems, collection bags, and various solutions such as saline, anticoagulants, media, columns, filters, and cell separation kits.

The mobilized leukopaks segment dominated the leukopaks market based on type.

By type, the leukopaks market is categorized into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized leukopaks segment dominated the leukopaks market in 2022. Mobilized leukopaks are mainly used in preclinical and clinical research in a variety of fields, including cancer immunotherapy, cell therapy, and regenerative medicine. Charles River Laboratories (US), Discovery Life Sciences (US), StemExpress (US), BioIVT (US), and Caltag Medsystems (UK) are some of the major players offering mobilized leukopaks for research and clinical applications.

North American region dominated the Leukapheresis market with the largest market share.

The Leukapheresis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America reported the largest share of the Leukapheresis market in 2022. The incidence and prevalence of leukemia are increasing in North America, due to factors such as environmental pollution, exposure to radiation, and unhealthy lifestyle habits. This is driving the demand for leukapheresis products, which are used to treat leukemia.

Key players in the leukapheresis products market include Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany). Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExpress, LLC (US), Charles River Laboratories International, Inc. (US), Caltag Medsystems Limited (UK), Lonza Group AG (Switzerland), and ZenBio (US). These companies adopted strategies such as product launches, business expansions, agreements, partnerships, and acquisitions to strengthen their presence in the Leukapheresis market.

Don’t miss out on business opportunities in Leukapheresis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Leukapheresis Market Size,  Share & Growth Report
Report Code
MD 6538
PR Published ON
8/31/2023
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Leukapheresis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home